Abstract:The p53 protein is a critical stress-response mediator and signal coordinator in cellular metabolism and environmental exposure to deleterious agents. In human populations, the p53 gene contains a common single nucleotide polymorphism (SNP) affecting codon 72 that determines whether a proline (P72) or an arginine (R72) is present at this amino acid position of the polypeptide. Previous studies carried out using human populations, mouse models, and cell culture analyses have provided evidence that this amino acid difference can alter p53 functional activities, and potentially also can affect clinical presentation of disease. The clinical presentation associated with many forms of liver disease is variable, but few of the responsible underlying genetic factors or molecular pathways have been identified. The aim of the present study was to investigate whether the p53 codon 72 polymorphism influences the cellular response to hepatic stresses. A humanized p53 knock-in (Hupki) mouse model was used to address this issue. Mice expressing either the P72 or R72 normal variation of p53 were given an acute-, intermittent- or a chronic challenge, associated with exposure to lipopolysaccharide, D-galactosamine, or a high-fat diet. The results reveal that the livers of the P72 and R72 mice exhibit notable differences in inflammatory and apoptotic response to these distinct forms of stress. Interestingly the influence of this polymorphism on the response to stress is context dependent, with P72 showing increased response to liver toxins (lipopolysaccharide and D-galactosamine), but R72 showing increased response to metabolic stress (high fat diet). When taken together, these data point to the p53 codon 72 polymorphism as an important molecular mediator of events contributing to hepatic inflammation and metabolic homeostasis.

Development of Better Aptamers: Structured Library Approaches, Selection Methods, and Chemical Modifications

In vitro selection of aptamers and their applications

SELEX: Critical factors and optimization strategies for successful aptamer selection

Current Status and Challenges of Aptamers Screening and Optimization.

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver.

Chemical Modifications for a Next Generation of Nucleic Acid Aptamers

Strategies for Improving Aptamer Screening Efficiency: Library Design, Awareness Innovation, and Instrument Assistance

Strategies to manipulate the performance of aptamers in SELEX, post-SELEX and microenvironment

Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment

A high-dimensional microfluidic approach for selection of aptamers with programmable binding affinities

Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications

Current developments of SELEX technologies and prospects in the aptamer selection with clinical applications

Evolution of Multi-Functional Capillary Electrophoresis for High-Efficiency Selection of Aptamers

Improving aptamer performance: key factors and strategies

Enhanced SELEX Platforms for Aptamer Selection with Improved Characteristics: A Review

Selection of aptamers targeting small molecules by capillary electrophoresis: Advances, challenges, and prospects

SELEX Modifications and Bioanalytical Techniques for Aptamer–Target Binding Characterization

Capture-SELEX for Aptamer Selection: A Short Review

Aptamers: Promising Reagents in Biomedicine Application

Application of SELEX and Aptamer in the Research of Proteins